Cytosorbents Corporation (CTSO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cytosorbents Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.85x | -2.39x | -1.69x | -2.06x | -7.40x | -39.48x |
| P/B Ratio | 6.74x | 4.46x | 2.13x | 1.91x | 2.90x | 3.91x |
| P/S Ratio | 1.07x | 1.39x | 1.59x | 1.95x | 4.53x | 7.84x |
| Profitability | ||||||
| Gross Margin | 71.5% | 70.6% | 70.6% | 59.8% | 72.5% | 72.0% |
| Operating Margin | -38.4% | -47.2% | -102.8% | -90.9% | -56.7% | -26.3% |
| Net Margin | -22.1% | -58.2% | -94.1% | -94.6% | -61.2% | -19.9% |
| EBITDA Margin | -34.0% | -42.7% | -89.7% | -86.5% | -53.9% | -24.6% |
| Liquidity | ||||||
| Current Ratio | 2.13x | 2.20x | 1.77x | 3.48x | 4.70x | 8.12x |
| Quick Ratio | 1.58x | 1.92x | 1.51x | 3.12x | 4.35x | 7.86x |
| Leverage | ||||||
| Debt/Equity | 4.93x | 2.42x | 0.79x | 0.52x | 0.22x | 0.01x |
YoY = year-over-year change. Source: FMP..